Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1999 1
2000 1
2003 1
2004 3
2005 5
2007 1
2008 1
2009 2
2010 2
2011 3
2012 1
2013 3
2014 3
2015 2
2016 1
2017 2
2018 4
2019 1
2020 2
2021 5
2022 2
2023 7
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.
Gillmore JD, Judge DP, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, Grogan M, Hanna M, Hoffman J, Masri A, Maurer MS, Nativi-Nicolau J, Obici L, Poulsen SH, Rockhold F, Shah KB, Soman P, Garg J, Chiswell K, Xu H, Cao X, Lystig T, Sinha U, Fox JC; ATTRibute-CM Investigators. Gillmore JD, et al. N Engl J Med. 2024 Jan 11;390(2):132-142. doi: 10.1056/NEJMoa2305434. N Engl J Med. 2024. PMID: 38197816 Clinical Trial.
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E; PIONEER-HF Investigators. Velazquez EJ, et al. N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11. N Engl J Med. 2019. PMID: 30415601 Clinical Trial.
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
González-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia-Pavia P, Chapman D, Gupta P, Glass O, Amass L; THAOS investigators. González-Moreno J, et al. Cardiol Ther. 2024 Mar;13(1):117-135. doi: 10.1007/s40119-023-00344-3. Epub 2023 Dec 20. Cardiol Ther. 2024. PMID: 38117424 Free PMC article.
Trouble in transit.
Alappan N, Tauras JM, Taub CC. Alappan N, et al. Among authors: tauras jm. Am J Med. 2010 Aug;123(8):709-10. doi: 10.1016/j.amjmed.2010.03.006. Am J Med. 2010. PMID: 20670724 No abstract available.
Systemic Amyloidosis: Is It ATTR or AL?
Singh J, Oliver-Krasinski J, Tauras J, Galen BT. Singh J, et al. Among authors: tauras j. Am J Med. 2023 Jul;136(7):652-654. doi: 10.1016/j.amjmed.2023.03.009. Epub 2023 Mar 29. Am J Med. 2023. PMID: 37001721 No abstract available.
The power of tax and price.
Chaloupka FJ, Tauras JA. Chaloupka FJ, et al. Among authors: tauras ja. Tob Control. 2011 Nov;20(6):391-2. doi: 10.1136/tobaccocontrol-2011-050235. Tob Control. 2011. PMID: 22020654 No abstract available.
Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.
Li W, Uppal D, Wang YC, Xu X, Kokkinidis DG, Travin MI, Tauras JM. Li W, et al. Among authors: tauras jm. Diagnostics (Basel). 2021 May 30;11(6):996. doi: 10.3390/diagnostics11060996. Diagnostics (Basel). 2021. PMID: 34070853 Free PMC article. Review.
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay.
Coelho T, Dispenzieri A, Grogan M, Conceição I, Waddington-Cruz M, Kristen AV, Wixner J, Diemberger I, Gonzalez-Moreno J, Maurer MS, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Cariou E, González-Duarte A, Glass O, Chapman D, Amass L; THAOS investigators. Coelho T, et al. Amyloid. 2023 Dec;30(4):445-448. doi: 10.1080/13506129.2023.2229484. Epub 2023 Jul 17. Amyloid. 2023. PMID: 37459334 Free article. No abstract available.
57 results